INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced the study outline for the pivotal Phase III clinical trials designed to evaluate BI 201335, its investigational once-daily ...
GlaxoSmithKline sold its investigational hepatitis C NS5a replication complex inhibitor to Johnson & Johnson subsidiary Janssen. The J&J unit said in a statement it plans to use Phase II GSK2336805 in ...
Researchers often work with a narrow range of compounds when making organic electronics, such as solar panels, light emitting diodes and transistors. Professor Tim Bender and Ph.D. Candidate Graham ...
A potential new drug for treatment of bipolar disorder (sometimes called manic depression) is being designed by researchers in Chicago and New York. The team hopes that their compound, which works as ...
This is a preview. Log in through your library . PNAS is the world's most-cited multidisciplinary scientific serial. It publishes high-impact research reports, commentaries, perspectives, reviews, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback